Pilot Phase 2 Study of Intratumoral G100 in Patients With Cutaneous T Cell Lymphoma
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2019
Price : $35 *
At a glance
- Drugs Glycopyranosyl lipid adjuvant (Primary) ; Glycopyranosyl lipid adjuvant (Primary) ; Nitrogen mustard compounds
- Indications Cutaneous T-cell lymphoma
- Focus Therapeutic Use
- 16 Dec 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 17 May 2019 Planned initiation date changed from 1 Feb 2019 to 1 Jun 2019.
- 04 Jan 2019 Planned initiation date changed from 1 Nov 2018 to 1 Feb 2019.